Investors Pump $30M Into Israeli Heart Failure Therapy
Executive Summary
WhiteSwell has received $30m in financing to support development of a catheter-based device for treating acute decompensated heart failure. The investment round was led by RA Capital Management and an InCube Ventures syndicate, with participation from other investors.